Paraproteinaemic Demyelinating Neuropathies

R. D.M. Hadden, E. Nobile-Orazio, C. Sommer, A. F. Hahn, I. Illa, E. Morra, J. Pollard, M. P.T. Lunn, P. Bouche, D. R. Cornblath, E. Evers, C. L. Koski, J. M. Léger, P. Van den Bergh, P. van Doorn, I. N. van Schaik

Research output: Chapter in Book/Report/Conference proceedingChapter

7 Scopus citations
Original languageEnglish (US)
Title of host publicationEuropean Handbook of Neurological Management
Subtitle of host publicationSecond Edition
Number of pages11
ISBN (Print)9781405185332
StatePublished - Sep 6 2010


  • Antibodies to myelin-associated glycoprotein (MAG) and other neural antigens
  • Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
  • Clinically useful guidelines-for patients with demyelinating neuropathy and a paraprotein (paraproteinaemic demyelinating neuropathy, PDN)
  • IgG or IgA paraproteinaemic demyelinating neuropathy
  • IgM paraproteinaemic demyelinating neuropathy
  • Paraproteinaemic demyelinating neuropathies
  • Patients with IgM PDN, meeting definite electrophysiological criteria for CIDP
  • Standard serum protein electrophoresis (SPEP) and serum immunoelectrophoresis (SIEP) and serum immunofixation electrophoresis (SIFE)
  • Typical syndromes of paraproteinaemic demyelinating neuropathy (PDN)
  • Waldenström's macroglobulinaemia-defined by presence of IgM (usually kappa) paraprotein

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this